Pro-inflammatory/antifibrogenic IFN-γ-expressing CD4+ T cell subset was present in higher amounts in active and inactive IBD (CD and UC) patients compared with healthy donors (1.7 ± 0.2%; P = 0.001). This evidence concerns the gene CD4 and inflammatory bowel disease.